Overall cardiovascular disease 2^nd level risk factors rank ordered by attributed DALYs in 1990 and 2021 for females (above) and males (below) in Chile. Red. by Camilo Briones-Valdivieso (21567535)

Subjects:

Relative change in cardiovascular diseases DALYs rates from 1990-1994 to 2017-2021 in Chile, for both genders. by Camilo Briones-Valdivieso (21567535)

Subjects:

Cardiovascular diseases ranked by DALYs in 1990 and 2021 for females (above) and males (below) in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative cardiomyopathy and myocarditis DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative ischaemic heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative stroke DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative overall CVD DALYs rate attributable to 2^nd-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall CVD disease burden in DALYs attributable to 1^st-level risk factors in Chile. DALYs rates are expressed per 100,000 individuals, with a 95% uncertainty interval. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Overall cardiovascular disease DALYs age-standardised rate over time 1990-2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative aortic aneurysm DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative overall CVD DALYs rate attributable to 1^st-level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Absolute and relative lower extremity peripheral arterial disease DALYs rate attributable to 2^nd level risk factors in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Percentage distribution of DALYs for cardiovascular diseases in 2021 in Chile. by Camilo Briones-Valdivieso (21567535)

Subjects:

Fig 5 - by Xiu-Qi Chen (13832389)

Subjects:

Significant condition. by Junxia Zhou (14381598)

“…Micro-cracks appeared in the cemented body by Day 7, resulting in a slight decrease in strength (3.92%) from Day 3 to Day 7. The formation of well-developed needle-like AFt, C-(A)S-H gel, and small-volume plate-like CH contributed to uniform cementation and a denser structure. …”

Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods. by Amrita Banerjee (382658)

“…<p>Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods.…”

Geniposide(Gen) significantly decreased the levels of TNF-α and MIP-1α in BALF of bleomycin-induced PF mice. by Jian-Bin Yin (19556105)

Flow chart of participants selection. by Linjia Duan (13276989)

Subjects: